Jiangang Zhang

Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Macrophage CCL7 promotes resistance to immunotherapy for colorectal cancer by regulating the infiltration of macrophages and CD8+ T cells.

Macrophage CCL7 promotes resistance to immunotherapy for colorectal cancer by regulating the infiltration of macrophages and CD8+ T cells.

Journal: Journal for immunotherapy of cancer
Published: November 01, 2025

Erratum: STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma: Erratum.

Erratum: STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma: Erratum.

Journal: Theranostics
Published: June 30, 2025

Regulation of Histone Acetylation During Inflammation Resolution.

Regulation of Histone Acetylation During Inflammation Resolution.

Journal: ImmunoTargets and therapy
Published: April 28, 2025

Cholesterol 25-Hydroxylase Enhances Myeloid-Derived Suppressor Cell (MDSC) Immunosuppression via the Stimulator of Interferon Genes (STING)-Tank-Binding Kinase 1 (TBK1)-Receptor-Interacting Protein Kinase 3 (RIPK3) Pathway in Colorectal Cancer.

Cholesterol 25-Hydroxylase Enhances Myeloid-Derived Suppressor Cell (MDSC) Immunosuppression via the Stimulator of Interferon Genes (STING)-Tank-Binding Kinase 1 (TBK1)-Receptor-Interacting Protein Kinase 3 (RIPK3) Pathway in Colorectal Cancer.

Journal: MedComm
Published: January 12, 2025

Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment.

Single-Cell Analysis of Posttranslational Modifications Identifies Immunosuppressive Macrophage Subtypes in the HBV-Positive Hepatocellular Carcinoma Microenvironment.

Journal: Cancer immunology research
Published: December 17, 2024

RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol-Triggered MET Activation.

RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol-Triggered MET Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 25, 2024

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma.

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma.

Journal: Theranostics
Published: August 29, 2024

LC-MS simultaneous profiling of acyl-CoA and acyl-carnitine in dynamic metabolic status.

LC-MS simultaneous profiling of acyl-CoA and acyl-carnitine in dynamic metabolic status.

Journal: Analytica chimica acta
Published: July 09, 2024

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma.

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma.

Journal: Clinical and translational medicine
Published: January 17, 2024

Retention time prediction and MRM validation reinforce the biomarker identification of LC-MS based phospholipidomics.

Retention time prediction and MRM validation reinforce the biomarker identification of LC-MS based phospholipidomics.

Journal: The Analyst
Published: December 11, 2023

GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

Journal: Theranostics
Published: November 27, 2023

Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells.

Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells.

Journal: Journal for immunotherapy of cancer
Published: November 20, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026